What is the purpose of this trial?
The purpose of this study is to determine the safety profile, tolerability and the Recommended Phase 2 Dose of the combination S64315 with venetoclax in patients with Acute Myeloid Leukaemia.
Institut de Recherches Internationales Servier (I.R.I.S.)
Start Date: 04/11/2019
End Date: 03/31/2022
Last Updated: 04/12/2019
Study HIC#: 2000024357